삼성서울병원

Ko En

병리과 조준훈 교수

진료분야
혈액병리, 두경부병리, 피부병리
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2019.08 순천향대학교 대학원 의학과 박사
2013.02 성균관대학교 대학원 의학과 석사
2008.02 성균관대학교 의과대학 의학사

경력

경력
2021.03 ~현재 삼성서울병원 병리과 전임대우조교수
2020.03 ~ 2021.02 삼성서울병원 병리과 진료조교수
2018.03 ~ 2020.02 삼성서울병원 병리과 임상조교수
2016.05 ~ 2018.02 순천향대학교천안병원 병리과 임상강사
2014.05 ~ 2016.04 국군수도병원 병리과
2013.05 ~ 2014.04 국방부조사본부 과학수사연구소
2009.03 ~ 2013.02 삼성서울병원 병리과 레지던트
2008.03 ~ 2009.02 강북삼성병원 인턴
  • ANN DERMATOL 2021 10.5021/ad.2021.33.3.222 Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA Oh1, SJ; Lee, J; Park, JH; Lee, JH; Cho, J; Ko, YH; Lee, D
    View PubMed
  • CANCER MANAG RES 2021 10.2147/CMAR.S309092 Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma Lee1, YP; Hong, JY; Yoon, SE; Cho, J; Shim, JH; Bang, Y; Kim, WS; Kim, SJ
    View PubMed
  • EXP HEMATOL ONCOL 2021 10.1186/s40164-021-00224-3 Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas Yoon1, SE; Cho, J; Kim, YJ; Ko, YH; Park, WY; Kim, SJ; Kim, WS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-89754-8 EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma Lee1, JY; Kim, JH; Bang, H; Cho, J; Ko, YH; Kim, SJ; Kim, WS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85332-0 Metabolic activity of extranodal NK/T cell lymphoma on F-18-FDG PET/CT according to immune subtyping Lim1, CH; Yoon, SE; Kim, SJ; Cho, J; Ko, YH; Lee, KH; Kim, WS
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.628807 Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Lee1, B; Lee, H; Cho, J; Yoon, SE; Kim, SJ; Park, WY; Kim, WS; Ko, YH
    View PubMed
  • J CANCER 2021 10.7150/jca.54434 Impact of transformation on the survival of patients diagnosed with follicular lymphoma that progressed within 24 months Yoon1, SE; Cho, J; Kim, WS; Kim, SJ
    View PubMed
  • J SURG ONCOL 2021 10.1002/jso.26386 Tumor dimension-dependent microscopic extensions of hypopharyngeal cancer: Therapeutic implications for larynx-preserving hypopharyngectomy Shin1, J; Lee, J; Hwang, N; Choi, SY; Park, W; Choi, N; Son, YI; Cho, J; Jeong, HS
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-021-07806-8 The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma Kang1, JH; Lee, SH; Lee, J; Choi, M; Cho, J; Kim, SJ; Kim, WS; Ko, YH; Yoo, HY
    View PubMed
  • GUT LIVER 2021 10.5009/gnl19288 Long-term Prognosis of Localized Lymphoid Hyperplasia of the Rectum Hong1, JT; Kim, ER; Park, SW; Kim, JW; Hong, SN; Chang, DK; Kim, YH; Cho, JH
    View PubMed
  • BLOOD 2020 Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma an open-label phase 2 study Kim1, SJ; Lim, JQ; Laurensia, Y; Cho, J; Yoon, SE; Lee, JY; Ryu, KJ; Ko, YH; Koh, Y; Cho, D; Lim, ST; Enemark, MB; D'amore, F; Bjerre, M; Ong, CK; Kim, WS
    View PubMed
  • CANCERS 2020 10.3390/cancers12123548 Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma Ryu1, KJ; Lee, JY; Choi, ME; Yoon, SE; Cho, J; Ko, YH; Shim, JH; Kim, WS; Park, C; Kim, SJ
    View PubMed
  • BLOOD 2020 10.1182/blood.2020005026 Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma Kim1, H; Jeong, H; Yamaguchi, M; Sohn, I; Yoon, SE; Byeon, S; Hur, JY; Koh, Y; Yoon, SS; Kim, EJ; Oguchi, M; Miyazaki, K; Taguchi, S; Yoon, DH; Cho, J; Ko, YH; Kim, SJ; Suzuki, R; Kim, WS
    View PubMed
  • LEUKEMIA 2020 10.1038/s41375-020-1000-0 Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma Lim1, JQ; Huang, DC; Tang, T; Tan, D; Laurensia, Y; Peng, RJ; Wong, EKY; Cheah, DMZ; Chia, BKH; Iqbal, J; Grigoropoulos, NF; Nairismagi, ML; Ng, CCY; Rajasegaran, V; Hong, HM; Kim, SJ; Cho, J; Tse, E; Mow, B; Cai, QC; Poon, L; Cai, QQ; Tan, J; Chan, JY; Lim, JX; Goh, YT; Phipps, C; Rotzschke, O; Cheng, CL; Ha, JCH; Khoo, LP; Loh, YSM; Au-Yeung, R; Chan, TSY; Kwong, YL; Hwang, W; Kim, WS; Bei, JX; Lin, TY; Ong, CK; Lim, ST
    View PubMed
  • GENE THER 2020 10.1038/s41434-020-0166-4 Effect of connective tissue growth factor gene editing using adeno-associated virus-mediated CRISPR-Cas9 on rabbit glaucoma filtering surgery outcomes Lee1, EJ; Han, JC; Park, DY; Cho, J; Kee, C
    View PubMed
  • ANN HEMATOL 2020 10.1007/s00277-020-04083-6 A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study Yoon1, SE; Eun, Y; Huh, K; Chung, CR; Yoo, IY; Cho, J; Cho, D; Ko, YH; Park, S; Kim, WS; Kim, SJ
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.198 Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial Kim1, SJ; Yoon, DH; Kim, JS; Kang, HJ; Lee, HW; Eom, HS; Hong, JY; Cho, J; Ko, YH; Huh, J; Yang, WI; Park, WS; Lee, SS; Suh, C; Kim, WS
    View PubMed
  • MODERN PATHOL 2020 10.1038/s41379-019-0392-8 Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression Cho1, J; Kim, SJ; Park, WY; Kim, J; Woo, J; Kim, G; Yoon, SE; Ko, YH; Kim, WS
    View PubMed
  • HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067 Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review Lee1, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH
    View PubMed
  • INT J CANCER 2019 10.1002/ijc.32228 Bridging genomics and phenomics of gastric carcinoma Cho1, J; Ahn, S; Son, DS; Kim, NKD; Lee, KW; Kim, S; Lee, J; Park, SH; Park, JO; Kang, WK; An, JY; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, S; Kim, KM
    View PubMed
  • MEDICINE 2019 10.1097/MD.0000000000017641 Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997-2016 An observational study Sim1, J; Takayama, T; Cho, J; Kim, SJ; Kim, WS; Ree, HJ; Ko, YH
    View PubMed
  • LEUKEMIA LYMPHOMA 2019 10.1080/10428194.2019.1573998 Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes Shin1, SH; Kim, YJ; Lee, D; Cho, D; Ko, YH; Cho, J; Park, WY; Park, D; Kim, SJ; Kim, WS
    View PubMed
  • J ORAL PATHOL MED 2019 10.1111/jop.12816 Risk of high-grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology Park1, W; Bae, H; Park, MH; Hwang, NY; Sohn, I; Cho, J; Jeong, HS
    View PubMed
  • PATHOL RES PRACT 2019 10.1016/j.prp.2018.11.010 MET is overexpressed in microsatellite instability-high gastric carcinoma Sim1, J; Heo, YJ; Bae, H; Shin, HC; Kim, B; Cho, J; Kim, ST; Lee, J; Kang, WK; Kim, KM
    View PubMed
  • ANN HEMATOL 2019 10.1007/s00277-018-3516-1 Validation of the Marginal Zone Lymphoma International Prognostic Index Hong1, J; Cho, J; Ko, YH; Kim, SJ; Kim, WS
    View PubMed
  • ORAL ONCOL 2019 10.1016/j.oraloncology.2019.01.003 Clinical outcomes and management of facial nerve in patients with parotid gland cancer and pretreatment facial weakness Park1, W; Park, J; Park, SI; Kim, H; Bae, H; Cho, J; Won, H; Park, M; Jeong, HS
    View PubMed
  • PATHOL RES PRACT 2019 10.1016/j.prp.2018.10.024 The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma Cho1, J; Kim, KM; Kim, HC; Lee, WY; Kang, WK; Park, YS; Ha, SY
    View PubMed
  • PATHOLOGY 2019 10.1016/j.pathol.2018.09.057 MMR protein immunohistochemistry and microsatellite instability in gastric cancers Cho1, J; Kang, SY; Kim, KM
    View PubMed
  • ANN SURG ONCOL 2018 10.1245/s10434-018-6731-z Factors Associated With Host Immune Response and Number of Lymph Nodes: A Large Retrospective Cohort Study Byeon1, SJ; Heo, YJ; Cho, J; An, JY; Choi, MG; Lee, JH; Bae, JM; Kim, MJ; Sohn, I; Kim, S; Kim, KM; Sohn, TS
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-32299-0 Computational measurement of tumor immune microenvironment in gastric adenocarcinomas Chang1, YH; Heo, YJ; Cho, J; Song, SY; Lee, J; Kim, KM
    View PubMed
  • J Diabetes Res 2018 10.1155/2018/5182606 Renal Ischemia-Reperfusion Injury in a Diabetic Monkey Model and Therapeutic Testing of Human Bone Marrow-Derived Mesenchymal Stem Cells Lee1, KW; Kim, TM; Kim, KS; Lee, S; Cho, J; Park, JB; Kwon, GY; Kim, SJ
    View PubMed
  • PATHOL RES PRACT 2018 10.1016/j.prp.2018.02.007 Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma Cho1, J; Ha, SY; Kim, SH; Sung, HH; Kwon, GY
    View PubMed

해당하는 결과가 없습니다.